NCT04229758View on ClinicalTrials.gov

Restarting Anticoagulation After Traumatic Intracranial Hemorrhage

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,100

Participants

Timeline

Start Date

October 31, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions
HemorrhageIntracranial HemorrhagesBleedingTrauma
Interventions
DRUG

Anticoagulants

DOAC for the prevention of thromboembolic events in patients with non-valvular AF or VTE.

Trial Locations (1)

78701

Dell Seton Medical Center at The University of Texas, Austin

All Listed Sponsors
lead

University of Texas at Austin

OTHER